Biocartis, phase 1
After a thorough analysis of the various options and with a view to the company’s needs, Mechelen was retained due to its excellence of quality, the suitability of the infrastructure and Intervest’s high level of active involvement.
Rudi Pauwels - Executive Chairman - Biocartis
Intercity Business Park
Generaal de Wittelaan 11b, Mechelen
6.458 m² GLA
2011
Project description
Biocartis is an innovative company active in the field of molecular diagnostics (MDx). It provides pioneering diagnostic solutions to improve clinical practice for patients, clinicians, activities and end products and the sector. The Biocartis’ MDx Idylla™ platform is a fully automated system which offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting. Biocartis is developing and marketing a rapidly expanding test menu addressing key, as yet unmet, clinical needs in oncology and infectious diseases.
Intervest helped Biocartis to find a high-quality, flexible location for its growth scenario.
